Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review

Ethical and Legal Considerations in Mitigating Pandemic Disease: Workshop Summary

Institute of Medicine (US) Forum on Microbial Threats
Washington (DC): National Academies Press (US); 2007.
The National Academies Collection: Reports funded by National Institutes of Health.
Free Books & Documents
Review

Ethical and Legal Considerations in Mitigating Pandemic Disease: Workshop Summary

Institute of Medicine (US) Forum on Microbial Threats.
Free Books & Documents

Excerpt

To examine the ethical and legal aspects of preparing for pandemic disease, the Institute of Medicine’s Forum on Microbial Threats hosted a public workshop on September 19–20, 2006, in Washington, DC. The presentations and discussions of the workshop were intended to explore the existing knowledge and unanswered questions pertaining to (but not limited to) the following topics:

  1. Understanding the Challenges of the Future by Examining the Past: Influenza/Smallpox/SARS

  2. Domestic, Regional, and International Preparedness Planning

  3. Disease Intervention Strategies—Quarantine, Containment, and Modeling

  4. Priority Setting for Access to Limited-Availability Health Care Resources

PubMed Disclaimer

Grants and funding

This project was supported by contracts between the National Academy of Sciences and the U.S. Department of Health and Human Services: National Institutes of Health, National Institute of Allergy and Infectious Diseases, Centers for Disease Control and Prevention, and Food and Drug Administration; U.S. Department of Defense: Global Emerging Infections Surveillance and Response System, Walter Reed Army Institute of Research, and Defense Threat Reduction Agency; U.S. Department of Veterans Affairs; U.S. Department of Homeland Security; U.S. Department of State; Lawrence Livermore National Laboratory; American Society for Microbiology; Sanofi Pasteur; Burroughs Wellcome Fund; Pfizer; GlaxoSmithKline; Infectious Diseases Society of America; and the Merck Company Foundation.

LinkOut - more resources